Product Code: TMRGL84850
Scope of Report
The report provides revenue of the global chronic pelvic pain treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic pelvic pain treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the chronic pelvic pain treatment market.
The report delves into the competitive landscape of the global chronic pelvic pain treatment market. Key players operating in the global chronic pelvic pain treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global chronic pelvic pain treatment market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Pelvic Pain Treatment Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Treatment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Disease Prevalence & Incidence Rate globally with key countries
- 5.2. Chronic Pelvic Pain Treatment Market Overview
- 5.3. Top 3 players operating in the market space
- 5.4. Reimbursement Scenario by Region/globally
6. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Treatment
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value & Volume Forecast, by Treatment, 2017-2031
- 6.3.1. Medications
- 6.3.1.1. Pain Relievers
- 6.3.1.2. Hormone Treatments
- 6.3.1.3. Antibiotics
- 6.3.1.4. Antidepressants
- 6.3.2. Surgery
- 6.3.2.1. Laparoscopic Surgery
- 6.3.2.2. Hysterectomy
- 6.3.3. Others
- 6.4. Market Attractiveness Analysis, by Treatment
7. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Distribution Channel
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 7.3.1. Retail Pharmacies & Drug stores
- 7.3.2. E-commerce
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Chronic Pelvic Pain Treatment Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value & Volume Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe/p>
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Pelvic Pain Treatment Market Analysis and Forecast
- 9.1. Introduction
- 9.2. Market Value & Volume Forecast, by Treatment, 2017-2031
- 9.2.1. Medications
- 9.2.1.1. Pain Relievers
- 9.2.1.2. Hormone Treatments
- 9.2.1.3. Antibiotics
- 9.2.1.4. Antidepressants
- 9.2.2. Surgery
- 9.2.2.1. Laparoscopic Surgery
- 9.2.2.2. Hysterectomy
- 9.2.3. Others
- 9.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 9.3.1. Retail Pharmacies & Drug stores
- 9.3.2. E-commerce
- 9.3.3. Others
- 9.4. Market Value & Volume Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Treatment
- 9.5.2. By Distribution Channel
- 9.5.3. By Country
10. Europe Chronic Pelvic Pain Treatment Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value & Volume Forecast, by Treatment, 2017-2031
- 10.2.1. Medications
- 10.2.1.1. Pain Relievers
- 10.2.1.2. Hormone Treatments
- 10.2.1.3. Antibiotics
- 10.2.1.4. Antidepressants
- 10.2.2. Surgery
- 10.2.2.1. Laparoscopic Surgery
- 10.2.2.2. Hysterectomy
- 10.2.3. Others
- 10.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 10.3.1. Retail Pharmacies & Drug stores
- 10.3.2. E-commerce
- 10.3.3. Others
- 10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Treatment
- 10.5.2. By Distribution Channel
- 10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Pelvic Pain Treatment Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value & Volume Forecast, by Treatment, 2017-2031
- 11.2.1. Medications
- 11.2.1.1. Pain Relievers
- 11.2.1.2. Hormone Treatments
- 11.2.1.3. Antibiotics
- 11.2.1.4. Antidepressants
- 11.2.2. Surgery
- 11.2.2.1. Laparoscopic Surgery
- 11.2.2.2. Hysterectomy
- 11.2.3. Others
- 11.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 11.3.1. Retail Pharmacies & Drug stores
- 11.3.2. E-commerce
- 11.3.3. Others
- 11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Treatment
- 11.5.2. By Distribution Channel
- 11.5.3. By Country/Sub-region
12. Latin America Chronic Pelvic Pain Treatment Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value & Volume Forecast, by Treatment, 2017-2031
- 12.2.1. Medications
- 12.2.1.1. Pain Relievers
- 12.2.1.2. Hormone Treatments
- 12.2.1.3. Antibiotics
- 12.2.1.4. Antidepressants
- 12.2.2. Surgery
- 12.2.2.1. Laparoscopic Surgery
- 12.2.2.2. Hysterectomy
- 12.2.3. Others
- 12.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 12.3.1. Retail Pharmacies & Drug stores
- 12.3.2. E-commerce
- 12.3.3. Others
- 12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Treatment
- 12.5.2. By Distribution Channel
- 12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Pelvic Pain Treatment Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value & Volume Forecast, by Treatment, 2017-2031
- 13.2.1. Medications
- 13.2.1.1. Pain Relievers
- 13.2.1.2. Hormone Treatments
- 13.2.1.3. Antibiotics
- 13.2.1.4. Antidepressants
- 13.2.2. Surgery
- 13.2.2.1. Laparoscopic Surgery
- 13.2.2.2. Hysterectomy
- 13.2.3. Others
- 13.3. Market Value & Volume Forecast, by Distribution Channel, 2017-2031
- 13.3.1. Retail Pharmacies & Drug stores
- 13.3.2. E-commerce
- 13.3.3. Others
- 13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Treatment
- 13.5.2. By Distribution Channel
- 13.5.3. By Country/Sub-region
14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Company Profiles
- 14.2.1. Bayer AG
- 14.2.1.1. Company overview
- 14.2.1.2. Financial overview
- 14.2.1.3. Business strategies
- 14.2.1.4. SWOT analysis
- 14.2.1.5. Recent developments
- 14.2.2. Becton, Dickinson and Company
- 14.2.2.1. Company overview
- 14.2.2.2. Financial overview
- 14.2.2.3. Business strategies
- 14.2.2.4. SWOT analysis
- 14.2.2.5. Recent developments
- 14.2.3. GlaxoSmithKline plc.
- 14.2.3.1. Company overview
- 14.2.3.2. Financial overview
- 14.2.3.3. Business strategies
- 14.2.3.4. SWOT analysis
- 14.2.3.5. Recent developments
- 14.2.4. Hospiinz
- 14.2.4.1. Company overview
- 14.2.4.2. Financial overview
- 14.2.4.3. Business strategies
- 14.2.4.4. SWOT analysis
- 14.2.4.5. Recent developments
- 14.2.5. Intuitive Surgical
- 14.2.5.1. Company overview
- 14.2.5.2. Financial overview
- 14.2.5.3. Business strategies
- 14.2.5.4. SWOT analysis
- 14.2.5.5. Recent developments
- 14.2.6. MAST PAK SURGICAL CORP
- 14.2.6.1. Company overview
- 14.2.6.2. Financial overview
- 14.2.6.3. Business strategies
- 14.2.6.4. SWOT analysis
- 14.2.6.5. Recent developments
- 14.2.7. Mayne Pharma Group Limited
- 14.2.7.1. Company overview
- 14.2.7.2. Financial overview
- 14.2.7.3. Business strategies
- 14.2.7.4. SWOT analysis
- 14.2.7.5. Recent developments
- 14.2.8. Medtronic
- 14.2.8.1. Company overview
- 14.2.8.2. Financial overview
- 14.2.8.3. Business strategies
- 14.2.8.4. SWOT analysis
- 14.2.8.5. Recent developments
- 14.2.9. Perrigo Company plc
- 14.2.9.1. Company overview
- 14.2.9.2. Financial overview
- 14.2.9.3. Business strategies
- 14.2.9.4. SWOT analysis
- 14.2.9.5. Recent developments